David Barter appointed as Cellebrite’s new CFO as Dana Gerner retires - Investing.com

David Barter appointed as Cellebrite’s new CFO as Dana Gerner retires By Company News Published 07/08/2025, 08:37 AM 0 © Cellebrite DI CLBT -2.61% TYSONS CORNER, Va. - Digital investigation solutions provider Cellebrite (NASDAQ:CLBT), a $3.65 billion market cap company with impressive gross profit margins of 84%, announced Tuesday the appointment of David Barter as its new Chief Financial Officer, effective immediately. Barter succeeds Dana Gerner, who is retiring after serving as the company’s CFO since 2014. Gerner will remain in an advisory role until Cellebrite reports its second-quarter 2025 financial results in August. During her 11-year tenure, she helped transform Cellebrite into a publicly traded company with consistent revenue growth, achieving a 22% year-over-year increase in the last twelve months. According to InvestingPro, the company maintains a strong balance sheet with more cash than debt. Barter brings over 30 years of financial leadership experience to the role, including significant experience with public technology companies. Most recently, he served as CFO at New Relic (NYSE:NEWR), where he helped grow the company to nearly $1 billion in annual revenue and supported its $6.5 billion sale. His previous positions include CFO roles at C3.ai (NYSE:AI) and Model N (NYSE:MODN), along with senior finance positions at Guidewire (NYSE:GWRE) Software, Microsoft (NASDAQ:MSFT) and General Electric (NYSE:GE). In his new position, Barter will oversee Cellebrite’s financial operations, including planning, accounting, reporting, treasury, corporate development, investor relations and operations. He will report directly to CEO Thomas E. Hogan. "I could not be more excited to join Cellebrite," Barter said in the press release statement. "The Company’s unique and compelling mission and focus on public safety captured my interest." Cellebrite, headquartered in Tysons Corner, Virginia and Petah Tikva, Israel, provides digital investigative solutions to public safety organizations, intelligence agencies and businesses worldwide. The company will report its second-quarter 2025 financial results on August 14, 2025. Despite a 30% decline in share price over the past six months, analysts maintain a strong buy consensus, with InvestingPro analysis revealing 10+ additional key insights about the company’s financial health and valuation. In other recent news, Cellebrite has announced its agreement to acquire Corellium for $170 million, with an additional $30 million contingent on performance milestones. The acquisition is expected to close in the summer of 2025, pending regulatory approvals. This move aims to enhance Cellebrite’s capabilities in digital investigations and smart device security. Corellium’s expertise in Arm-based virtualization software will support Cellebrite’s offerings in both public safety and private sector security solutions. Chris Wade, Corellium’s founder, will join Cellebrite as Chief Technology Officer, bringing valuable experience in vulnerability research and security testing. The acquisition is anticipated to expand Cellebrite’s total addressable market and extend its reach across various sectors. The financial impact on Cellebrite’s 2025 revenue and other metrics will be disclosed after the deal’s completion. J.P. Morgan Securities LLC acted as Corellium’s exclusive financial advisor in this transaction. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. Should you be buying CLBT right now? ProPicks AI evaluates CLBT alongside thousands of other companies every month using 100+ financial metrics. Using powerful AI to generate exciting stock ideas, it looks beyond popularity to assess fundamentals, momentum, and valuation. The AI has no bias—it simply identifies which stocks offer the best risk-reward based on current data with notable past winners that include Super Micro Computer (+185%) and AppLovin (+157%). Want to know if CLBT is currently featured in any ProPicks AI strategies, or if there are better opportunities in the same space? See Stocks 0 Latest comments Post Comment Guidelines Loading next article… Indices Commodities Bonds Stocks 1D 1W 1M 6M 1Y 5Y Max US 30 46,060.80 +101.4 +0.22% US 500 6,496.10 +19.0 +0.29% Dow Jones 45,960.11 -469.38 -1.01% S&P 500 6,477.16 -114.74 -1.74% Nasdaq 21,408.08 -521.74 -2.38% S&P 500 VIX 27.69 +0.25 +0.91% Dollar Index 99.83 +0.122 +0.12% Most Popular Articles News Analysis Iran conflict latest: Trump pauses Iran energy plant strikes by 10 days By Investing.co... Mar 27, 2026 Solid rebound in Hormuz tanker flows backs Trump’s claim By Investing.co... Mar 26, 2026 Oil prices tick down, set for weekly losses on Middle East de-escalation hopes By Investing.co... Mar 27, 2026 Gold falls on mixed messaging regarding Iran; Trump asserts peace talks ongoing By Investing.co... Mar 26, 2026 Stocks slump on fading hopes for Iran peace talks; Nasdaq in correction territory By Investing.co... Mar 26, 2026 More News Market Movers Most Active Gainers % Losers % Name Last Chg. % Vol. NVDA 171.24 -4.16% 186.15M TSLA 372.11 -3.59% 55.52M MU 355.46 -6.97% 54.52M GOOGL 280.92 -3.44% 39.08M MSFT 365.97 -1.37% 36.84M META 547.54 -7.96% 35.78M SNDK 603.17 -11.02% 19.02M Trending Stocks Name Last Chg. % Vol. META 547.54 -7.96% 35.78M MU 355.46 -6.97% 54.52M MSFT 365.97 -1.37% 36.84M NVDA 171.24 -4.16% 186.15M SNDK 603.17 -11.02% 19.02M Show more Markets Watchlist Ask WarrenAI Stocks Picked by AI Alerts Top Brokers Breaking News Install Our App Scan QR code to install app Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers. © 2007-2026 - Fusion Media Limited. All Rights Reserved.